全文获取类型
收费全文 | 5792篇 |
免费 | 435篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 49篇 |
儿科学 | 121篇 |
妇产科学 | 101篇 |
基础医学 | 677篇 |
口腔科学 | 67篇 |
临床医学 | 776篇 |
内科学 | 1185篇 |
皮肤病学 | 93篇 |
神经病学 | 475篇 |
特种医学 | 166篇 |
外科学 | 981篇 |
综合类 | 46篇 |
一般理论 | 3篇 |
预防医学 | 517篇 |
眼科学 | 86篇 |
药学 | 434篇 |
中国医学 | 7篇 |
肿瘤学 | 454篇 |
出版年
2023年 | 59篇 |
2022年 | 102篇 |
2021年 | 317篇 |
2020年 | 180篇 |
2019年 | 243篇 |
2018年 | 270篇 |
2017年 | 190篇 |
2016年 | 166篇 |
2015年 | 250篇 |
2014年 | 259篇 |
2013年 | 364篇 |
2012年 | 463篇 |
2011年 | 491篇 |
2010年 | 236篇 |
2009年 | 165篇 |
2008年 | 291篇 |
2007年 | 278篇 |
2006年 | 298篇 |
2005年 | 217篇 |
2004年 | 206篇 |
2003年 | 185篇 |
2002年 | 156篇 |
2001年 | 81篇 |
2000年 | 66篇 |
1999年 | 63篇 |
1998年 | 33篇 |
1997年 | 30篇 |
1996年 | 31篇 |
1995年 | 31篇 |
1994年 | 12篇 |
1993年 | 20篇 |
1992年 | 45篇 |
1991年 | 41篇 |
1990年 | 41篇 |
1989年 | 33篇 |
1988年 | 28篇 |
1987年 | 27篇 |
1986年 | 24篇 |
1985年 | 32篇 |
1984年 | 27篇 |
1983年 | 13篇 |
1979年 | 15篇 |
1978年 | 9篇 |
1974年 | 11篇 |
1973年 | 13篇 |
1971年 | 13篇 |
1970年 | 12篇 |
1968年 | 14篇 |
1967年 | 8篇 |
1966年 | 13篇 |
排序方式: 共有6238条查询结果,搜索用时 15 毫秒
131.
132.
133.
134.
Theken KN Schuck RN Edin ML Tran B Ellis K Bass A Lih FB Tomer KB Poloyac SM Wu MC Hinderliter AL Zeldin DC Stouffer GA Lee CR 《Atherosclerosis》2012,222(2):530-536
ObjectivePreclinical and genetic epidemiologic studies suggest that modulating cytochrome P450 (CYP)-mediated arachidonic acid metabolism may have therapeutic utility in the management of coronary artery disease (CAD). However, predictors of inter-individual variation in CYP-derived eicosanoid metabolites in CAD patients have not been evaluated to date. Therefore, the primary objective was to identify clinical factors that influence CYP epoxygenase, soluble epoxide hydrolase (sEH), and CYP ω-hydroxylase metabolism in patients with established CAD.MethodsPlasma levels of epoxyeicosatrienoic acids (EETs), dihydroxyeicosatrienoic acids (DHETs), and 20-hydroxyeicosatetraenoic acid (20-HETE) were quantified by HPLC–MS/MS in a population of patients with stable, angiographically confirmed CAD (N = 82) and healthy volunteers from the local community (N = 36). Predictors of CYP epoxygenase, sEH, and CYP ω-hydroxylase metabolic function were evaluated by regression.ResultsObesity was significantly associated with low plasma EET levels and 14,15-EET:14,15-DHET ratios. Age, diabetes, and cigarette smoking also were significantly associated with CYP epoxygenase and sEH metabolic activity, while only renin-angiotensin system inhibitor use was associated with CYP ω-hydroxylase metabolic activity. Compared to healthy volunteers, both obese and non-obese CAD patients had significantly higher plasma EETs (P < 0.01) and epoxide:diol ratios (P < 0.01), whereas no difference in 20-HETE levels was observed (P = NS).ConclusionsCollectively, these findings suggest that CYP-mediated eicosanoid metabolism is dysregulated in certain subsets of CAD patients, and demonstrate that biomarkers of CYP epoxygenase and sEH, but not CYP ω-hydroxylase, metabolism are altered in stable CAD patients relative to healthy individuals. Future studies are necessary to determine the therapeutic utility of modulating these pathways in patients with CAD. 相似文献
135.
Cromer MK Starker LF Choi M Udelsman R Nelson-Williams C Lifton RP Carling T 《The Journal of clinical endocrinology and metabolism》2012,97(9):E1774-E1781
Context: The underlying molecular alterations causing sporadic parathyroid adenomas that drive primary hyperparathyroidism have not been thoroughly defined. Objective: The aim of the study was to investigate the occurrence of somatic mutations driving tumor formation and progression in sporadic parathyroid adenoma using whole-exome sequencing. Design: Eight matched tumor-constitutional DNA pairs from patients with sporadic parathyroid adenomas underwent whole-exome capture and high-throughput sequencing. Selected genes were analyzed for mutations in an additional 185 parathyroid adenomas. Results: Four of eight tumors displayed a frame shift deletion or nonsense mutation in MEN1, which was accompanied by loss of heterozygosity of the remaining wild-type allele. No other mutated genes were shared among the eight tumors. One tumor harbored a Y641N mutation of the histone methyltransferase EZH2 gene, previously linked to myeloid and lymphoid malignancy formation. Targeted sequencing in the additional 185 parathyroid adenomas revealed a high rate of MEN1 mutations (35%). Furthermore, this targeted sequencing identified an additional parathyroid adenoma that contained the identical, somatic EZH2 mutation that was found by exome sequencing. Conclusion: This study confirms the frequent role of the loss of heterozygosity of chromosome 11 and MEN1 gene alterations in sporadic parathyroid adenomas and implicates a previously unassociated methyltransferase gene, EZH2, in endocrine tumorigenesis. 相似文献
136.
137.
Wang Y Marling SJ Zhu JG Severson KS DeLuca HF 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(22):8501-8504
The development of experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis, has been studied in mice that were (i) vitamin D-deficient, (ii) minus the vitamin D receptor, (iii) minus a vitamin D 25-hydroxylase, and (iv) minus the vitamin D 25-hydroxyvitamin D-1α-hydroxylase. EAE development was markedly suppressed in mice lacking the vitamin D receptor and partially suppressed in vitamin D-insufficient mice. However, the absence of either of the two key hydroxylases (i.e., 25-hydroxylase and 1α-hydroxylase) neither inhibits nor enhances the development of EAE. These results indicate that vitamin D and the vitamin D receptor are required for the development of EAE. The results also suggest that 1,25-dihydroxyvitamin D(3) may not play a role in this autoimmune response. 相似文献
138.
Akitaka Ito David J. Stewart Zhen Fang M. Kyle Brennaman Thomas J. Meyer 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(38):15132-15135
Distance-dependent energy transfer occurs from the Metal-to-Ligand Charge Transfer (MLCT) excited state to an anthracene-acrylate derivative (Acr-An) incorporated into the polymer network of a semirigid poly(ethyleneglycol)dimethacrylate monolith. Following excitation, to Acr-An triplet energy transfer occurs followed by long-range, Acr-3An—Acr-An → Acr-An—Acr-3An, energy migration. With methyl viologen dication (MV2+) added as a trap, Acr-3An + MV2+ → Acr-An+ + MV+ electron transfer results in sensitized electron transfer quenching over a distance of approximately 90 Å. 相似文献
139.
140.
Litten RZ Fertig JB Falk DE Ryan ML Mattson ME Collins JF Murtaugh C Ciraulo D Green AI Johnson B Pettinati H Swift R Afshar M Brunette MF Tiouririne NA Kampman K Stout R;NCIG Study Group 《Alcoholism, clinical and experimental research》2012,36(3):406-416
Background: Despite advances in developing medications to treat alcohol dependence, few such medications have been approved by the Food and Drug Administration. Identified molecular targets are encouraging and can lead to the development and testing of new compounds. Atypical antipsychotic medications have been explored with varying results. Prior research suggests that the antipsychotic quetiapine may be beneficial in an alcohol‐dependent population of very heavy drinkers. Methods: In this double‐blind, placebo‐controlled trial, 224 alcohol‐dependent patients who reported very heavy drinking were recruited across 5 clinical sites. Patients received either quetiapine or placebo and Medical Management behavioral intervention. Patients were stratified on gender, clinical site, and reduction in drinking prior to randomization. Results: No differences between the quetiapine and placebo groups were detected in the primary outcome, percentage heavy‐drinking days, or other drinking outcomes. Quetiapine significantly reduced depressive symptoms and improved sleep but had no effect on other nondrinking outcomes. Results from a subgroup analysis suggest that patients who reduced their drinking prior to randomization had significantly better drinking outcomes during the maintenance phase (p < 0.0001). No significant interactions, however, were observed between reducer status and treatment group. Finally, quetiapine was generally well tolerated. Statistically significant adverse events that were more common with quetiapine versus placebo include dizziness (14 vs. 4%), dry mouth (32 vs. 9%), dyspepsia (13 vs. 2%), increased appetite (11 vs. 1%), sedation (15 vs. 3%), and somnolence (34 vs. 9%). Conclusions: This multisite clinical trial showed no efficacy for quetiapine compared with placebo at reducing alcohol consumption in heavy‐drinking alcohol‐dependent patients. 相似文献